kaiser permanente glp-1 coverage news An employer's guide to GLP-1s for obesity Paving the way for expanded

To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management

Samtidigt vcker utvecklingen frgor om hur lkemedlen anvnds nr de blir billigare och lttare att f tag p

Expert Rev Endocrinol Metab 2025;20:147-52.ArticlePubMed 96

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Medicaid and Medicare coverage for Mounjaro can vary